Waters (NYSE:WAT) Shares Sold Off Rep. Kevin Hern

Representative Kevin Hern (Republican-Oklahoma) recently sold shares of Waters Corporation (NYSE:WAT). In a filing disclosed on September 01st, the Representative disclosed that they had sold between $1,001 and $15,000 in Waters stock on August 13th. The trade occurred in the Representative’s “HERN FAMILY REVOCABLE TRUST” account.

Representative Kevin Hern also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Marsh & McLennan Companies (NYSE:MRSH) on 8/24/2026.
• Sold $15,001 – $50,000 in shares of Medtronic (NYSE:MDT) on 8/24/2026.
• Sold $50,001 – $100,000 in shares of Home Depot (NYSE:HD) on 8/24/2026.
• Sold $50,001 – $100,000 in shares of Procter & Gamble (NYSE:PG) on 8/24/2026.
• Sold $1,001 – $15,000 in shares of Lowe’s Companies (NYSE:LOW) on 8/24/2026.
• Sold $15,001 – $50,000 in shares of Microsoft (NASDAQ:MSFT) on 8/21/2026.
• Sold $1,001 – $15,000 in shares of Veralto (NYSE:VLTO) on 8/21/2026.
• Sold $15,001 – $50,000 in shares of Honeywell Aerospace (NASDAQ:HONA) on 8/19/2026.
• Sold $1,001 – $15,000 in shares of Colgate-Palmolive (NYSE:CL) on 8/19/2026.
• Sold $1,001 – $15,000 in shares of Biogen (NASDAQ:BIIB) on 8/18/2026.

Waters Stock Up 1.6%

Shares of WAT opened at $412.15 on Thursday. The business’s fifty day moving average price is $390.51 and its two-hundred day moving average price is $350.41. The firm has a market capitalization of $40.49 billion, a price-to-earnings ratio of 102.78, a PEG ratio of 2.36 and a beta of 1.19. Waters Corporation has a 52 week low of $282.77 and a 52 week high of $426.22. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.29 and a current ratio of 1.86.

Waters (NYSE:WAT) last announced its quarterly earnings data on Tuesday, August 4th. The medical instruments supplier reported $3.05 earnings per share for the quarter, beating the consensus estimate of $3.01 by $0.04. The business had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.62 billion. Waters had a net margin of 3.58% and a return on equity of 11.27%. Waters’s revenue was up 113.3% compared to the same quarter last year. During the same period in the prior year, the business posted $2.95 earnings per share. Waters has set its Q3 2026 guidance at 3.950-4.050 EPS and its FY 2026 guidance at 14.450-14.650 EPS. On average, analysts predict that Waters Corporation will post 14.56 earnings per share for the current year.

Wall Street Analyst Weigh In

WAT has been the subject of a number of research reports. Wall Street Zen raised Waters from a “hold” rating to a “buy” rating in a research note on Saturday, August 29th. Barclays boosted their price objective on shares of Waters from $425.00 to $460.00 and gave the company an “overweight” rating in a research report on Wednesday, August 5th. Wells Fargo & Company increased their target price on Waters from $370.00 to $400.00 and gave the stock an “equal weight” rating in a report on Wednesday, August 5th. HSBC boosted their price target on Waters from $415.00 to $435.00 and gave the company a “buy” rating in a report on Wednesday, June 3rd. Finally, Citigroup lifted their target price on Waters from $425.00 to $470.00 and gave the company a “buy” rating in a research report on Monday, August 10th. Three analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $424.35.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the stock. Brighton Jones LLC grew its stake in shares of Waters by 112.9% in the fourth quarter. Brighton Jones LLC now owns 1,269 shares of the medical instruments supplier’s stock valued at $471,000 after buying an additional 673 shares in the last quarter. Integrated Wealth Concepts LLC increased its stake in shares of Waters by 2.9% during the 1st quarter. Integrated Wealth Concepts LLC now owns 1,048 shares of the medical instruments supplier’s stock worth $386,000 after purchasing an additional 30 shares during the last quarter. Goldman Sachs Group Inc. raised its holdings in shares of Waters by 3.6% in the 1st quarter. Goldman Sachs Group Inc. now owns 200,051 shares of the medical instruments supplier’s stock valued at $73,733,000 after purchasing an additional 6,976 shares during the period. Empowered Funds LLC lifted its stake in Waters by 16.6% in the 1st quarter. Empowered Funds LLC now owns 1,126 shares of the medical instruments supplier’s stock valued at $415,000 after purchasing an additional 160 shares during the last quarter. Finally, Sivia Capital Partners LLC bought a new position in Waters during the second quarter worth about $232,000. 94.01% of the stock is currently owned by institutional investors.

Insider Activity

In other news, Director Christopher A. Kuebler sold 3,626 shares of the firm’s stock in a transaction that occurred on Thursday, August 6th. The stock was sold at an average price of $397.94, for a total value of $1,442,930.44. Following the completion of the sale, the director directly owned 17,808 shares of the company’s stock, valued at $7,086,515.52. This trade represents a 16.92% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. 0.31% of the stock is currently owned by insiders.

About Representative Hern

Kevin Hern (Republican Party) is a member of the U.S. House, representing Oklahoma’s 1st Congressional District. He assumed office on November 13, 2018. His current term ends on January 3, 2027.

Hern (Republican Party) is running for re-election to the U.S. House to represent Oklahoma’s 1st Congressional District. He declared candidacy for the 2026 election.

Kevin Hern went into business as a McDonald’s franchisee in 1999. He acquired 10 McDonald’s franchises by 2012. He served on the McDonald’s National Leadership Team for 13 years, including the tax policy team, the insurance corporation, and as chairman of the economics team. From 2011 to 2015, he was chairman of the finance committee of the Oklahoma Turnpike Authority.

About Waters

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.